Search results

Found 1,514 pages
AUTHOR: Anna Smith

Results per page

10 20 50 100

Sort by

Relevance Date

29 Aug 2019:

EU approval for Tecentriq combo

The approval of the monoclonal antibody was based on results from the Phase III IMpassion130 study. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/eu_approval_for_tecentriq_combo_1300025

15 Jan 2020:

PTC submits MAA for new gene therapy

The company expects a CHMP decision in the second half of 2020. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/ptc_submits_maa_for_new_gene_therapy_1322392

25 Mar 2020:

COVID-19: AstraZeneca to distribute masks as ASCO goes virtual

PHE has also been awarded $500,000 by the US FDA  to bolster the international response. - News - PharmaTimes

by Anna Smith|Anna Smith

https://www.pharmatimes.com/news/covid-19_astrazeneca_to_distribute_masks_as_asco_goes_virtual_1329991

29 Aug 2019:

FDA green light for Fasenra

Currently there are no FDA-approved treatments for eosinophilic oesophagitis. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/fda_green_light_for_fasenra_1300027

21 Jun 2019:

EU approval for Novo’s Esperoct

The decision follows the positive opinion from the CHMP. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/eu_approval_for_novos_esperoct_1292131

18 Feb 2020:

Beovu bags EU approval in wet AMD

The drug is the first EC-approved anti-VEGF treatment to demonstrate superior resolution of retinal fluid, compared to Bayer's Eylea. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/beovu_bags_eu_approval_in_wet_amd_1326378

21 Jan 2020:

EMA licenses Mayzent for MS

Novartis also expects NICE and SMC decisions in the first half of 2020. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/ema_licenses_mayzent_for_ms_1322928

1 Oct 2019:

Invokana bags FDA approval

The treatment has been approved to reduce the risk of hospitalisation for heart failure in certain patients with type II diabetes. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/invokana_bags_fda_approval_1311532

21 Aug 2019:

NHS to reimburse Hemlibra

The 'life-changing' drug will be reimbursed for certain people with severe congenital haemophilia A. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/nhs_to_reimburse_hemlibra_1298460

6 Sep 2019:

LIVI partners with Boots

The NHS Long Term Plan states that all patients should have access to online and video consultations by 2021. - News - PharmaTimes

by Anna Smith

https://www.pharmatimes.com/news/livi_partners_with_boots_1300885